COSCIENS Biopharma Inc. (LON:0UGB)
London
· Delayed Price · Currency is GBP · Price in CAD 4.200
-0.050 (-1.18%)
At close: Jan 22, 2025
COSCIENS Biopharma Employees
COSCIENS Biopharma had 40 employees as of December 31, 2024. The number of employees increased by 28 or 233.33% compared to the previous year.
Employees
40
Change
28
Growth
233.33%
Revenue / Employee
174.73K GBP
Profits / Employee
-339.84K GBP
Market Cap
7.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40 | 28 | 233.33% |
| Dec 31, 2020 | 12 | -44 | -78.57% |
| Dec 31, 2014 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| Shell | 96,000 |
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| Rolls-Royce Holdings | 42,400 |
| British American Tobacco p.l.c. | 48,989 |
| Rio Tinto Group | 60,000 |
| RELX PLC | 36,400 |
COSCIENS Biopharma News
- 5 weeks ago - COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire
- 7 weeks ago - COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents - Newsfile Corp
- 4 months ago - COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - GlobeNewsWire
- 6 months ago - COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization - GlobeNewsWire
- 8 months ago - COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs - GlobeNewsWire